Kingspan Quote - KRX

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

70.10

Bid

70.10

Offer

71.05

Volume

69.95 Day's Range 71.45

0.00 52 Week Range 0.00

Previous Close

71.20

Open

71.45

Last Trade

70.099999

Last Trade Time

Average Volume (3m)

Financial Volume

VWAP

Acquisition(s)

Keryx Biopharmaceuticals Adds Three Clinical-Stage Oncology Drug Candidates to its Pipeline, Including a Novel, First-in-Class, Oral AKT-Inhibitor In Phase II Signs Agreement to Acquire...

Application for Block Admission

Keryx Biopharmaceuticals, Inc. News NEW YORK, Dec. 19 -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX; AIM: KRX), today announced that application has been made for block admission to trading on...

Keryx Biopharmaceuticals, Inc. News

Keryx Biopharmaceuticals, Inc. News NEW YORK, Nov. 26 -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX; AIM: KRX), today announced that application has been made to the London Stock Exchange for...

Keryx Biopharmaceuticals, Inc. Announces Collaboration

Keryx Biopharmaceuticals, Inc. Announces S.O.A.R. (Sulodexide Open Access Research) Program Collaboration with the University of Michigan Top researcher to explore potential beneficial effects of...

Keryx Biopharmaceuticals Raises $15 Million Equity

Keryx Biopharmaceuticals, Inc. Raises $15 Million In Private Equity Transaction With Institutional Investors NEW YORK, Nov. 18 / -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX; AIM: KRX), a...

Keryx to Hold Investor Conference Call

Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2003 Financial Results - Keryx to Hold Investor Conference Call Tomorrow, Tuesday, November 11, 2003 at 10:00 AM EST - NEW YORK, Nov. 10...

Keryx Biopharmaceuticals Conference Call on 3Q 2003

Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2003 Financial Results on Tuesday, November 11, at 10:00 a.m. EST NEW YORK, Nov. 7 -- Keryx Biopharmaceuticals, Inc...

REMINDER: Keryx CEO to Provide KRX-101 Update Today

REMINDER: Keryx Biopharmaceuticals CEO to Provide KRX-101 Update Today at the Rodman & Renshaw Techvest Healthcare Conference NEW YORK, Oct. 21 -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX;...

Statement re Start of KRX-101 Phase II/III Trial

Keryx Biopharmaceuticals, Inc. Initiates Phase II/III Clinical Program of KRX-101 (Sulodexide Gelcaps) for Treatment of Diabetic Nephropathy KRX-101 has FDA Fast-Track Designation To Treat A...

Keryx to Present at Rodman & Renshaw Techvest Conference

Keryx Biopharmaceuticals to Present at Rodman & Renshaw Techvest Healthcare Conference NEW YORK, Oct. 16 -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX, London AIM: KRX), a biopharmaceutical...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

KRX - Frequently Asked Questions (FAQ)

What is the current Kingspan share price?

The current share price of Kingspan is 70.10 €

What is the 1 year trading range for Kingspan share price?

Kingspan has traded in the range of 0.00 € to 0.00 € during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDDOrdinary Shares	0.0044 € (633.33%)	25.87k
M5ZManz Automation Ag Npv	1.75 € (106.86%)	2.62M
69CCara Therapeutics Inc	0.4656 € (84.03%)	95.22k
AWY0Percheron Therapeutics Ltd	0.007 € (75.00%)	758.82k
0PV2Moovly Media Inc	0.0065 € (62.50%)	500.18k
1RR1Rokmaster Resources Corp	0.006 € (-50.00%)	4k
D4GDataMetrex AI Ltd	0.003 € (-46.43%)	406.92k
QNTQuantum Corp	34.80 € (-40.00%)	26.8k
36GGBM Resources Limited	0.004 € (-38.46%)	223.04k
N7ENatural Cool Holdings Limited	0.0165 € (-35.29%)	65k
AXIAtos SE	0.0021 € (-8.70%)	811.16M
DMLSayona Mining Limited	0.0149 € (-6.88%)	3.6M
RQ0DWave Quantum Inc	6.228 € (-27.80%)	3.45M
D7GNel ASA	0.2548 € (-3.34%)	2.93M
M5ZManz Automation Ag Npv	1.75 € (106.86%)	2.62M